Generic drug­maker an­nounces cheaper al­ter­na­tive to EpiPen

The Washington Times Daily - - NATION -

TREN­TON | Generic drug­maker San­doz an­nounced plans Thurs­day to start sell­ing an al­ter­na­tive to the EpiPen in the U.S. early next year.

The EpiPen in­jec­tor is used to halt life-threat­en­ing al­ler­gic re­ac­tions to in­sect bites, nuts and other foods. Brand-name EpiPen, which dom­i­nates the mar­ket, has been in short sup­ply since spring be­cause of pro­duc­tion problems.

San­doz will sell pre­filled sy­ringes with the same medicine, the hor­mone ep­i­neph­rine, un­der the name Sym­jepi. The price will be $250 for two, with­out in­sur­ance.

Two generic ver­sions of EpiPen are sold in the U.S. for $300 a pair, in­clud­ing one from EpiPen seller My­lan.

The com­pany started sell­ing its own generic af­ter it was blasted for re­peated hikes that pushed up prices

from $94 to $608 for two brand-name EpiPens.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.